Kurt A. Gustafson
2020 - Spectrum Pharmaceuticals
In 2020, Kurt A. Gustafson earned a total compensation of $2.1M as Former Executive Vice President and Chief Financial Officer at Spectrum Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
Bonus | $270,000 |
---|---|
Option Awards | $747,566 |
Salary | $540,000 |
Stock Awards | $390,000 |
Other | $143,386 |
Total | $2,090,952 |
Gustafson received $747.6K in option awards, accounting for 36% of the total pay in 2020.
Gustafson also received $270K in bonus, $540K in salary, $390K in stock awards and $143.4K in other compensation.
Rankings
In 2020, Kurt A. Gustafson's compensation ranked 5,319th out of 13,090 executives tracked by ExecPay. In other words, Gustafson earned more than 59.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,319 | 59th |
Manufacturing | 2,187 | 61st |
Chemicals And Allied Products | 874 | 61st |
Drugs | 753 | 62nd |
Pharmaceutical Preparations | 564 | 61st |
Gustafson's colleagues
We found four more compensation records of executives who worked with Kurt A. Gustafson at Spectrum Pharmaceuticals in 2020.
News
OmniAb CEO Matthew Foehr's 2023 pay falls 60% to $2.6M
April 26, 2024
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019